A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer

J.S.W. Lind, A.M.C. Dingemans, H.J.M. Groen, F.B.J.M. Thunnissen, O. Bekers, D.A.M. Heideman, R.J. Honeywell, E. Giovannetti, G.J. Peters, P.E. Postmus, R.J. van Suylen, E.F. Smit

Research output: Contribution to journalArticleAcademicpeer-review

80 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)3078-3087
JournalClinical Cancer Research
Issue number11
Publication statusPublished - 2010

Cite this